Cough Monitoring Study
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The aim of the study is to establish the accuracy of a new device designed specifically to record and detect cough episodes.
Cough is an important defense mechanism of the respiratory tract. The presence of chronic cough may indicate the presence of underlying diseases, including reflux. Despite the increased number of patients suffering from cough in the ENT and GI practice, to date, there has been no method/device to objectively assess the frequency of cough episodes in a given patient.
PULMOTRACK-CC, manufactured by KarmelSonix (Haifa, Israel), has recently introduced an innovative device that is able to record cough episodes and then automatically detect and count them with the help of a specific software program. This study will assess the accuracy of this novel cough monitoring and counting technology and validate potential clinical use in patients with chronic cough.
| Condition |
|---|
|
Cough Reflux |
| Study Type: | Observational |
| Study Design: | Observational Model: Case Control Time Perspective: Prospective |
| Official Title: | Monitoring Cough Device - Step 1 and 2 |
- Accuracy of Cough Device [ Time Frame: 24 hours post device placement ] [ Designated as safety issue: No ]The aim of the study is to establish the accuracy of a new device designed specifically to record and detect cough episodes.
| Enrollment: | 33 |
| Study Start Date: | November 2010 |
| Estimated Study Completion Date: | January 2013 |
| Primary Completion Date: | January 2012 (Final data collection date for primary outcome measure) |
| Groups/Cohorts |
|---|
Cough as Primary Complaint
|
Healthy Volunteers
|
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Non-Probability Sample |
Patients who present to the ENT or GI clinics at Vanderbilt Medical Center with a chief complaint of chronic cough will be eligible for participation in this study. Patients who meet eligibility requirements will be able to participate regardless of sex, social status, or ethnicity.
Inclusion Criteria:
Arm 1: healthy volunteers:
- Male and female volunteers 18 years of age and older
- No history of chronic or acute cough and throat clearing
- Ability to read a 5th grade script written in English for approximately 20 minutes
Arm 2: patients:
- Male and female volunteers 18 years of age and older
- Cough as chief complaint
- Referred to the GI clinic to evaluate if reflux is the cause of their chief complaint
- pH testing for standard of care purposes
Exclusion Criteria:
- Subjects who are not able to give informed consent
Contacts and Locations| United States, Tennessee | |
| Vanderbilt University Medical Center | |
| Nashville, Tennessee, United States, 37232 | |
| Principal Investigator: | Michael Vaezi, MD, PhD | Vanderbilt University |
More Information
No publications provided
| Responsible Party: | Michael Vaezi, Medical Director, Vanderbilt University |
| ClinicalTrials.gov Identifier: | NCT01263626 History of Changes |
| Other Study ID Numbers: | MCD 1-2 |
| Study First Received: | December 16, 2010 |
| Last Updated: | December 19, 2012 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Vanderbilt University:
|
Cough Chronic Cough Reflux |
Additional relevant MeSH terms:
|
Cough Respiration Disorders Respiratory Tract Diseases Signs and Symptoms, Respiratory Signs and Symptoms |
ClinicalTrials.gov processed this record on May 16, 2013